Many of today's leading drugs are directly injected into the patient's body, which is why the global injectable drug delivery market is anticipated to grow at a rate of 8.67 percent through 2027. This growth is reflective of Dr. Reddy's injectable portfolio for medical specialties. The team at Dr. Reddy's has made a concerted effort to ensure that their injectable delivery system exceeds patient need and improves the injectable experience.
Dr. Reddy's Laboratories have honed its capabilities in the injectable and inhalation space through world-class capabilities and best-in-class teams. Their work has resulted in a strong track record in developing, marketing, and distributing generic injectables. These credentials and operations contribute to the accessibility and affordability of medications.
Dr. Reddy's most recently launched injectable is Desmopressin Acetate Injection USP, 4 mcg/mL Single-dose Ampules, a therapeutic equivalent generic version of DDAVP (desmopressin acetate) Injection 4 mcg/mL, approved by the FDA. This product is a strong addition to the injectable offerings in the U.S. market and reflects a commitment to act with speed to find innovative solutions and accelerate access to much-needed medicines.
Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.
Marti Jones brings more than 20 years of integrated communications experience from world-renowned organizations. Marti’s career has grown from raising awareness and funds for the American Red Cross before and after 9/11 to leading strategy for brands such as Mayo Clinic, Duke Health, and M Health Fairview, which included communications for change management and COVID-19. Marti's messaging portfolios are supported by her academic background and proven methodology, as she taught writing at the University of Minnesota and honed her craft at UnitedHealth, UCare, and RXinsider, Revel Health and Hill and Knowlton. Marti received her master’s degree in public affairs and administration from George Washington University and Bachelor of Arts degrees in communications and psychology from Augustana University.
This post is related to:
Generics, Brand Name, Biotech
